Found 12 matching trials
Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix⢠to 18-55 Year-Old Adults PHASE3 The purpose of this study is to demonstrate, in 18-55 year old adults, the ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines PHASE3 The purpose of this study is to evaluate immunogenicity and safety of menin...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers PHASE3 This study evaluates the immunogenicity and safety of the meningococcal con...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612 PHASE2 This study has 2 phases, a vaccination phase and a long-term follow-up phas...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study in Adolescents/Adults to Evaluate Non-inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate Vaccine PHASE2 Meningococcal disease is mostly caused by N. meningitidis of serogroups A, ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Comparison of GSK Biologicals' Meningococcal Vaccine (GSK134612) and Licensed MenC-CRM197 Vaccine in Healthy Children PHASE3 The purpose of the study is to investigate whether or not GSK Biologicals' ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra⢠to 12-23 Month-Old Children PHASE3 The purpose of this study is to demonstrate, in 12-23 month old children, t...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Comparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-vaccinated Subjects PHASE2 In this study, subjects who were vaccinated with a meningococcal polysaccha...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Pertussis and Meningitis C Concomitant Vaccination in Adolescents PHASE4 The trial includes groups receiving various combinations of meningitis C an...
Show More Location
Gloucestershire primary care
Learn More & Join Trial
Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination PHASE3 The purpose of this study is to evaluate the immunogenicity, reactogenicity...
Show More Location
GSK Investigational Site
Learn More & Join Trial